Advertisement
JOGC
ONCOLOGY| Volume 41, ISSUE 4, P450-458, April 2019

Download started.

Ok

Oncologic and Surgical Outcomes of Robotic Versus Open Radical Hysterectomy for Cervical Cancer

Published:December 07, 2018DOI:https://doi.org/10.1016/j.jogc.2018.09.013

      Abstract

      Objective

      In view of the recent controversy concerning the use of minimally invasive radical hysterectomy as primary treatment for early stage cervical cancer, this study compared the survival and perioperative outcomes in a cohort of patients who underwent radical hysterectomy either by laparotomy or by robotics.

      Methods

      This retrospective study compared all consecutive patients with early stage cervical cancer since the beginning of the Division of Gynecologic Oncology at the Jewish General Hospital in 2003, who underwent robotic radical hysterectomy (n = 74) with a cohort of all consecutive patients from the immediate past who underwent open radical hysterectomy (n = 24) for early stage cervical cancer. All patients were treated at the Jewish General Hospital in Montréal (Canadian Task Force Classification II-2).

      Results

      The median follow-up time for the robotic group was 46 months. During that time, 7% and 17% of patients in the robotic group and the laparotomy group had disease recurrence, respectively (P = 0.12). Cox multivariate regression showed no statistically significant effect of surgical approach on overall survival (hazard ratio 1.50, P = 0.63) or on progression-free survival (hazard ratio 0.29, P = 0.07). Patients in the robotic cohort had significantly shorter median hospital stays (1 day vs. 7 days, P < 0.001), and their overall incidence of postoperative complications was lower (13% vs. 50%, P < 0.001). Median estimated blood loss for robotics was also significantly lower (82 mL vs. 528 mL, P < 0.001).

      Conclusion

      Based on the data on a limited number of patients in a Canadian context, robotic radical hysterectomy did not lead to worse oncologic outcomes and was associated with improved short-term surgical outcomes. One might consider the evaluation of more personalized surgical decision making.

      Résumé

      Objectif

      À la lumière de la récente controverse entourant le recours à une hystérectomie radicale à effraction minimale comme traitement de première intention dans les cas de cancer du col de l'utérus de stade précoce, cette étude compare la survie et les issues périopératoires au sein d'une cohorte de patientes ayant subi une hystérectomie radicale par laparotomie ou par chirurgie robotique.

      Méthodologie

      Cette éude rétrospective a comparé toutes les patientes consécutives présentant un cancer du col de l'ut'rus de stade précoce depuis la mise sur pied du programme de gynéco-oncologie de l'Hôpital général juif en 2003. Une cohorte de toutes les patientes consécutives ayant subi une hystérectomie radicale par chirurgie robotique (n = 74) à été comparée à une cohorte de toutes les patientes consécutives ayant subi une hystérectomie radicale par laparotomie (n = 24) pour la même maladie durant la période précédant immédiatement le début des chirurgies robotiques. Toutes les patientes ont été traitées à l'Hôpital général juif de Montréal (classification II-2 du Groupe d'étude canadien).

      Résultats

      La durée médiane du suivi pour le groupe de chirurgie robotique était de 46 mois. Durant cette période, 7% des patientes de ce groupe et 17% des patientes du groupe de laparotomie ont présenté une récidive (P = 0,12). Une régression de Cox multivariée n'a montré aucun effet significatif de l'approche chirurgicale sur la survie globale (rapport de risque 1,50; P = 0,63) et sur la survie sans progression (rapport de risque 0,29; P = 0,07). Le séjour à l'hôpital médian des patientes ayant subi une chirurgie robotique était significativement inférieur (un jour contre sept jours, P < 0,001), et l'incidence globale de complications postopératoires dans cette cohorte était plus faible (13 % contre 50 %, P < 0,001). La perte sanguine estimée médiane était aussi significativement plus faible pour la chirurgie robotique (82 ml contre 528 ml, P < 0,001).

      Conclusion

      D'après des données issues d'un nombre limité de patientes traitées au Canada, on peut conclure que l'hystérectomie radicale par chirurgie robotique ne serait pas associée à des issues oncologiques comparativement défavorables et serait associée à de meilleures issues chirurgicales à court terme. On pourrait envisager l'évaluation d'une prise de décision chirurgicale plus personnalisée.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Obstetrics and Gynaecology Canada
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Committee on Practice Bulletins: Gynecology
        ACOG practice bulletin. Diagnosis and treatment of cervical carcinomas, number 35, May 2002.
        Obstet Gynecol. 2002; 99: 855-867
        • Meigs JV
        Carcinoma of the cervix, the Wertheim operation.
        Surg Gynecol Obstet. 1944; 78: 195
        • Meigs JV
        Radical hysterectomy with bilateral pelvic lymph node dissections; a report of 100 patients operated on five or more years ago.
        Am J Obstet Gynecol. 1951; 62: 854-870
        • Canis M
        • Mage G
        • Wattiez A
        • et al.
        [Does endoscopic surgery have a role in radical surgery of cancer of the cervix uteri?].
        J Gynecol Obstet Biol Reprod (Paris). 1990; 19: 921
        • Gil-Moreno A
        • Puig O
        • Pérez-Benavente MA
        • et al.
        Total laparoscopic radical hysterectomy (type II-III) with pelvic lymphadenectomy in early invasive cervical cancer.
        J Minim Invasive Gynecol. 2005; 12: 113-120
        • Nezhat F
        • Mahdavi A
        • Nagarsheth NP
        Total laparoscopic radical hysterectomy and pelvic lymphadenectomy using harmonic shears.
        J Minim Invasive Gynecol. 2006; 13: 20-25
        • Estape R
        • Lambrou N
        • Diaz R
        • et al.
        A case matched analysis of robotic radical hysterectomy with lymphadenectomy compared with laparoscopy and laparotomy.
        Gynecol Oncol. 2009; 113: 357-361
        • Halliday D
        • Lau S
        • Vaknin Z
        • et al.
        Robotic radical hysterectomy: comparison of outcomes and cost.
        J Robot Surg. 2010; 4: 211-216
        • Frumovitz M
        • dos Reis R
        • Sun CC
        • et al.
        Comparison of total laparoscopic and abdominal radical hysterectomy for patients with early-stage cervical cancer.
        Obstet Gynecol. 2007; 110: 96-102
        • Sert BM
        • Boggess JF
        • Ahmad S
        • et al.
        Robot-assisted versus open radical hysterectomy: a multi-institutional experience for early-stage cervical cancer.
        Eur J Surg Oncol. 2016; 42: 513-522
        • Zanagnolo V
        • Minig L
        • Rollo D
        • et al.
        Clinical and oncologic outcomes of robotic versus abdominal radical hysterectomy for women with cervical cancer: experience at a referral cancer center.
        Int J Gynecol Cancer. 2016; 26: 568-574
        • Wang YZ
        • Deng L
        • Xu HC
        • et al.
        Laparoscopy versus laparotomy for the management of early stage cervical cancer.
        BMC Cancer. 2015; 15: 928
        • Boggess JF
        • Gehrig PA
        • Cantrell L
        • et al.
        A case-control study of robot-assisted type III radical hysterectomy with pelvic lymph node dissection compared with open radical hysterectomy.
        Am J Obstet Gynecol. 2008; 199: 357.e1-357.e7
        • Ramirez PT
        • Frumovits M
        • Pareja R
        • et al.
        Phase III randomized trial of laparoscopic or robotic versus abdominal radical hysterectomy in patients with early stage cervical cancer: LACC Trial.
        in: Presented at the 49th annual meeting of the Society of Gynecologic Oncology, New Orleans, LAMarch 24–27, 2018 (Available at:) (Accessed on October 15, 2018)
        • Melamed A
        • Chen L
        • Keating NL
        • et al.
        Comparative effectiveness of minimally-invasive staging surgery in women with early-stage cervical cancer.
        in: Presented at the 49th annual meeting of the Society of Gynecologic Oncology, New Orleans, LAMarch 24–27, 2018 (Available at:) (Accessed on October 15, 2018)
        • Magrina JF
        • Kho RM
        • Weaver AL
        • et al.
        Robotic radical hysterectomy: comparison with laparoscopy and laparotomy.
        Gynecol Oncol. 2008; 109: 86-91
        • Magrina JF
        • Kho R
        • Magtibay PM
        Robotic radical hysterectomy: technical aspects.
        Gynecol Oncol. 2009; 113: 28-31
        • Shazly SA
        • Murad MH
        • Dowdy SC
        • et al.
        Robotic radical hysterectomy in early stage cervical cancer: a systematic review and meta-analysis.
        Gynecol Oncol. 2015; 138: 457-471
        • Ramirez PT
        • Adams S
        • Boggess JF
        • et al.
        Robotic-assisted surgery in gynecologic oncology: a Society of Gynecologic Oncology consensus statement. Developed by the Society of Gynecologic Oncology's Clinical Practice Robotics Task Force.
        Gynecol Oncol. 2012; 124: 180—4
        • Nezhat FR.
        • Datta MS
        • Liu C
        • et al.
        Robotic radical hysterectomy versus total laparoscopic radical hysterectomy with pelvic lymphadenectomy for treatment of early cervical cancer.
        JSLS. 2008; 12: 227-237
        • Cantrell LA
        • Mendivil A
        • Gehrig PA
        • et al.
        Survival outcomes for women undergoing type III robotic radical hysterectomy for cervical cancer: a 3-year experience.
        Gynecol Oncol. 2010; 117: 260-265
        • Hoogendam JP
        • Verheijen RH
        • Wegner I
        • et al.
        Oncological outcome and long-term complications in robot-assisted radical surgery for early stage cervical cancer: an observational cohort study.
        BJOG. 2014; 121: 1538-1545
        • Segaert A
        • Traen K
        • Van Trappen P
        • et al.
        Robot-assisted radical hysterectomy in cervical carcinoma: the Belgian experience.
        Int J Gynecol Cancer. 2015; 25: 1690-1696
        • Shah CA
        • Beck T
        • Liao JB
        • et al.
        Surgical and oncologic outcomes after robotic radical hysterectomy as compared to open radical hysterectomy in the treatment of early cervical cancer.
        J Gynecol Oncol. 2017; 28: e82
      1. Margul DJ Yang J, Seagle B, et al. Outcomes and costs of open, robotic, and laparoscopic radical hysterectomy for stage IB1 cervical cancer. Presented at the American Society of Clinical Oncology annual meeting, Chicago, IL, June 1--5, 2018. Available at:http://abstracts.asco.org/214/AbstView_214_226091.html. Accessed on October 15, 2018.